| Share


Focus on expansion of BluGlass’ EpiBlu custom services business

Sydney, 11 April 2018: BluGlass Limited (ASX: BLG), a global leader commercialising breakthrough Remote Plasma Chemical Vapour Deposition (RPCVD) technology, has appointed Brad Siskavich to the full-time role of Vice President of Business Development. Mr Siskavich will join the company to lead the expansion of the BluGlass custom services business, EpiBlu Pty Ltd, and will be based in the US.

Brad Siskavich has more than 20 years’ experience in developing, marketing and commercialising new technologies in start-up and high-growth environments in the compound semiconductor, photovoltaic (solar), laser, photonics and opto-electronics industries. He has previously worked in senior research and business development roles at companies that include Emcore, Oxford Instruments and Masimo Semiconductor.

BluGlass Managing Director Giles Bourne said, “Appointing Brad full-time is an exciting step for BluGlass and the EpiBlu team and represents a new commitment to building our custom service revenues. He brings significant industry expertise to BluGlass, with deep research and business development experience across the sector. His role has a global focus for the EpiBlu service business, and provides us with a permanent resource based in the US to develop export markets there for our RPCVD technology. As our commercialisation plans around RPCVD continue to become firmer, and as we continue to add to and expand on our joint venture partnerships, it’s essential that we develop and prepare our export expertise ahead of time.”

Brad Siskavich said, “After reviewing BluGlass’ current technical status and results from the RPCVD technology, I’m excited to be joining the BluGlass team. The unique advantages of RPCVD I believe will become a key enabler in developing new technologies and market opportunities. The specialist compound semiconductor markets, including microLED, UV LED, laser diode and power semiconductor markets, are showing rapid growth. These new technologies will require advanced flexibility and performance, and this is where the RPCVD technology will have a competitive edge.”

EpiBlu is the service arm and wholly-owned subsidiary of BluGlass and offers specialised custom epitaxy, foundry and characterisation services at its state-of-the-art facility in Sydney. EpiBlu will continue to expand its operations, providing services to support MOCVD (metal-organic chemical vapour deposition) technology - the industry’s incumbent technology platform - and BluGlass’ unique low temperature RPCVD technology. This revenue generating business also creates new opportunities to introduce the advantages of BluGlass’ proprietary RPCVD technology to customers at the cutting edge of the opto-electronics industry.

- Ends -

About BluGlass: BluGlass Limited (ASX: BLG) is a global leader commercialising breakthrough Remote Plasma Chemical Vapour Deposition (RPCVD) silicon wafer manufacturing technology. BluGlass has invented a new process using RPCVD to grow advanced materials such as gallium nitride (GaN) and indium gallium nitride (InGaN). These materials are crucial to the production of high-efficiency devices such as power electronics applications, and light emitting diodes (LEDs) used in next-generation vehicle lighting, virtual reality systems and device backlighting.

The RPCVD technology, because of its low temperature and flexible nature, offers many potential benefits over existing technologies including higher efficiency, lower cost, substrate flexibility (including GaN on silicon) and scalability.

BluGlass was spun off from Macquarie University in 2005 and listed in 2006.

Media Contact: Stefanie Winwood +61 2 9334 2300 swinwood@bluglass.com.au